| DeLTA 2.0: A deep learning pipeline for quantifying single-cell spatial and temporal dynamics OM O’Connor, RN Alnahhas, JB Lugagne, MJ Dunlop PLoS computational biology 18 (1), e1009797, 2022 | 72 | 2022 |
| The motility regulator flhDC drives intracellular accumulation and tumor colonization of Salmonella V Raman, N Van Dessel, OM O’Connor, NS Forbes Journal for ImmunoTherapy of Cancer 7, 1-16, 2019 | 25 | 2019 |
| Longitudinal Single‐Cell Imaging of Engineered Strains with Stimulated Raman Scattering to Characterize Heterogeneity in Fatty Acid Production N Tague, H Lin, JB Lugagne, OM O'Connor, D Burman, WW Wong, ... Advanced Science 10 (20), 2206519, 2023 | 6 | 2023 |
| Implantable devices for cell therapy and related methods LE Barney, M Beauregard, G Carmona, FC Gonzalez, R Heidebrecht, ... US Patent App. 17/280,802, 2022 | 1 | 2022 |
| Implantable particles and related methods LE Barney, M Beauregard, G Carmona, FC Gonzalez, R Heidebrecht, ... US Patent App. 17/045,127, 2021 | 1 | 2021 |
| Cell-TRACTR: A transformer-based model for end-to-end segmentation and tracking of cells OM O'Connor, MJ Dunlop bioRxiv, 2024.07. 11.603075, 2024 | | 2024 |
| Compositions, devices, and methods for factor vii therapy LE Barney, M Beauregard, G Carmona, FC Gonzalez, R Heidebrecht, ... US Patent App. 17/598,154, 2023 | | 2023 |
| Longitudinal single-cell chemical imaging of engineered strains reveals heterogeneity in fatty acid production N Tague, H Lin, JB Lugagne, OM O’Connor, D Burman, WW Wong, ... bioRxiv, 2022 | | 2022 |
| Compositions, devices, and methods for treating fabry disease LE Barney, M Beauregard, G Carmona, FC Gonzalez, R Heidebrecht, ... US Patent App. 17/598,176, 2022 | | 2022 |
| Correcting bleeding disorders using blood clotting factors produced in vivo by shielded engineered allogeneic cells G Carmona, L Barney, J Sewell, R Newman, C Carroll, O O'Connor, ... HUMAN GENE THERAPY 30 (11), A192-A192, 2019 | | 2019 |
| Correcting Bleeding Disorders Using Blood Clotting Factors Produced by Shielded Engineered Allogenic Cells G Carmona, L Barney, J Sewell, R Newman, C Carroll, O O'Connor, ... MOLECULAR THERAPY 27 (4), 338-338, 2019 | | 2019 |
| Enzyme Replacing Therapy in MPS-1 Mice by Enzyme Produced In Vivo by Shielded Engineered Allogeneic Cells E Makino, B Fluharty, D Tietz, L Barney, J Sewell, C Carroll, J Huang, ... MOLECULAR THERAPY 27 (4), 241-242, 2019 | | 2019 |
| Correcting hemophilia A using human FVIII produced in vivo by Afibromer (TM) shielded engineered allogeneic cells G Carmona, L Barney, J Sewell, R Newman, C Carroll, O O'Connor, ... HAEMOPHILIA 25, 98-98, 2019 | | 2019 |
| Intracellular Invasion of Salmonella Drives Tumor Colonization of the Bacteria in vitro V Raman, N Van Dessel, O O'Connor, NS Forbes 2017 AIChE Annual Meeting, 2017 | | 2017 |
| Upregulation of Salmonella motility in tumors improves dispersion, colonization and intracellular invasion of the bacteria V Raman, NV Dessel, O O'Connor, NS Forbes Cancer Research 77 (13_Supplement), 5136-5136, 2017 | | 2017 |
